Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
SHH: 600613.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Feng Bin
- Employees
- 1,426
- Headquarters
- Shanghai, China
- IPO year
- 1992
- Market cap
- CN¥2.8B
- Website
- https://www.gzsq.com
Loading 600613…
Loading profile data…Frequently asked questions about 600613
What does Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS) do?
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, tonic products, cold and cough, children's medicine, an...
Where does 600613.SS trade?
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS) trades on the Shanghai Stock Exchange.
What sector is 600613.SS in?
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.?
Feng Bin is the chief executive officer of Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS).
Where is Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. headquartered?
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. is headquartered in China.
Does 600613.SS pay a dividend?
Yes — Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS) paid a trailing twelve-month dividend of CNY 0.15 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600613.SS go public?
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS) completed its initial public offering in 1992.